1 Failure to achieve complete resolution |
9 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Subtotals only |
1.1 Studies assessed as having no COI |
5 |
392 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.54 [0.46, 0.64] |
1.2 Studies assessed as potentially having COI |
4 |
2167 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.78 [0.73, 0.83] |
2 Decrease in erythema score |
2 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Totals not selected |
2.1 Studies assessed as potentially having COI |
2 |
|
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
3 Decrease in pruritus score |
3 |
|
Std. Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
3.1 Studies assessed as potentially having COI |
3 |
699 |
Std. Mean Difference (IV, Fixed, 95% CI) |
-0.55 [-0.85, -0.26] |
4 Side effects |
6 |
|
Risk Ratio (M-H, Random, 95% CI) |
Subtotals only |
4.1 Studies assessed as having no COI |
2 |
206 |
Risk Ratio (M-H, Random, 95% CI) |
1.82 [1.07, 3.09] |
4.2 Studies assessed as potentially having COI |
4 |
782 |
Risk Ratio (M-H, Random, 95% CI) |
0.75 [0.52, 1.09] |